18F-FDG PET in non-Hodgkin's lymphoma: qualitative or quantitative?
about
The evolving role of response-adapted PET imaging in Hodgkin lymphomaMethodological considerations in quantification of oncological FDG PET studies.18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Management of Aggressive Non-Hodgkin's B-Cell LymphomaMulti-observation PET image analysis for patient follow-up quantitation and therapy assessment.Diffuse Large B-Cell Lymphoma: Prospective Multicenter Comparison of Early Interim FLT PET/CT versus FDG PET/CT with IHP, EORTC, Deauville, and PERCIST Criteria for Early Therapeutic MonitoringProteomic and metabolic prediction of response to therapy in gastrointestinal cancers.Imaging outcomes in cardiovascular clinical trials.Interim fluorodeoxyglucose positron emission tomography for early response assessment in diffuse large B cell lymphoma: where are we now?Clinical applications of positron emission tomography in sarcoma management.Impact of FDG-PET/CT in the management of lymphoma.Usefulness of F-18 FDG PET/CT in the assessment of disseminated Mycobacterium avium complex infection.Standardized added metabolic activity (SAM): a partial volume independent marker of total lesion glycolysis in liver metastases.Chemotherapy-induced modulation of [18F]Fluoro-2-deoxy-D-glucose incorporation at the tumour cell level.Relationship Between Dual Time Point FDG PET/CT and Clinical Prognostic Indexes in Patients with High Grade Lymphoma: a Pilot Study.Midtreatment 18F-fluorodeoxyglucose positron-emission tomography in aggressive non-Hodgkin lymphoma.
P2860
Q26750993-103A038A-99EA-4068-A6A5-E0AABB876343Q33915164-A843693A-022A-477E-90EC-D057440FCC6EQ35855599-2C202133-3FD7-4E4C-8BD1-2ED2C1BE89A0Q36437342-935AC8D6-F097-46BD-AFB2-2EBB6B35A1D3Q37069297-8F5554FB-724F-43C8-8117-9607E2279365Q37405931-74CD65DC-C8A1-4435-9412-D77AEAFA38BBQ37535498-89AC184C-3D23-47A4-B7DC-41A024824874Q37650211-020CCC33-1364-445C-9F79-BC65CF8C2900Q37845828-19DE7F04-18E2-4E35-8879-456C5474DE86Q37950857-40FDFA03-12A3-4E64-8F46-CA8C1A897731Q43269920-147181CB-FF9A-4098-9A3E-B9F6DE56C85EQ43919851-9935A739-2DE8-40F2-97C1-12FAA68C5617Q46943359-C75FC050-34C7-4C2B-8FF9-9DE815FD6E51Q48535641-2D947ACC-2D10-412F-AF9C-14EB9829B353Q51646044-6272DC2B-7931-40BF-9754-A03ABF0EA1F8
P2860
18F-FDG PET in non-Hodgkin's lymphoma: qualitative or quantitative?
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
18F-FDG PET in non-Hodgkin's lymphoma: qualitative or quantitative?
@en
18F-FDG PET in non-Hodgkin's lymphoma: qualitative or quantitative?
@nl
type
label
18F-FDG PET in non-Hodgkin's lymphoma: qualitative or quantitative?
@en
18F-FDG PET in non-Hodgkin's lymphoma: qualitative or quantitative?
@nl
prefLabel
18F-FDG PET in non-Hodgkin's lymphoma: qualitative or quantitative?
@en
18F-FDG PET in non-Hodgkin's lymphoma: qualitative or quantitative?
@nl
P1476
18F-FDG PET in non-Hodgkin's lymphoma: qualitative or quantitative?
@en
P2093
Wolfgang A Weber
P304
P356
10.2967/JNUMED.107.042911
P407
P577
2007-10-01T00:00:00Z